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ABSTRACT 
Objective: Formulate a nanocarrier for enhancing the anti-inflammatory activity of thymoquinone (Tq), a major active constituent of Nigella sativa.  
Methods: Nanoformulation of Tq was developed by low energy emulsification techniques. NanoTqs were pre-screened by different thermodynamic 
stability tests, followed by in vitro release, zeta potential, viscosity, the transmittance (%), globule size distribution and ex vivo studies. The 
morphology of the optimized NanoTq was determined by transmission electron microscopy (TEM) which revealed fairly spherical shape and good 
correlation with particle size distribution study. The formulation used for assessment of the anti-inflammatory potential and permeability 
enhancement contained mixture of essential oil of Nigella sativa: Capryol 90 (3:7, 10%, v/v), Tween 80 (21.75%, v/v), PEG 400 (7.25%, v/v) and 
double distilled water (61%, v/v).  
Results: The in vitro permeation of Tq from optimized formulations was found extremely significant (p<0.001) in comparison to apiTq. The steady 
state flux (Jss), the permeability coefficient (Kp) and enhancement ratio (Er) of NanoTq gel was determined and compared with apiTq. The 
comparative anti-inflammatory effects of the optimized formulations NanoTq, apiTq and DicloGel was assessed on the edema in the carrageenan-
induced paw model in Wistar rats. Therapeutic potential of NanoTq was found statistically extremely significant (P<0.0001) compared to apiTq and 
insignificant comparable with standard DicloGel. Storage stability of NanoTq showed insignificant changes in the zeta potential, droplet size and 
was free from any physical instability.  
Conclusion: The optimized nano formulation with a lower dose of Tq showed better anti-inflammatory effects, indicating greater absorption 
capability through the stratum corneum.  
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Nigella sativa L or Black seed (Family: Ranunculaceae) has been 
regarded as a blessing and healing food additive in the Islamic culture 
and extensively used as a medicinal herb [1]. Chemical analysis of 
Nigella sativa L has shown the existence of tremendous active 
constituents with multifaceted therapeutic applicability. Nigella sativa 
Essential oil (EO) and its main active constituent, thymoquinone (Tq), 
are extensively reported to exhibit protective effects against many 
diseases largely attributable to their high antioxidant activity [2, 3]. 
Thymol, thymoquinone (Tq), thymoquinone, and carvacrol which are 
found in the Nigella sativa EO have been used in various therapies 
including as an analgesic [4], antioxidant, anti-aging [5, 6], and 
anticancer [7] agent and in Parkinsonism [8], Alzheimer’s [9], stroke 
[10] and various neurological disorders. The anti-inflammatory 
property of these compounds have also been examined in various 
studies like induced rheumatoid arthritis in the rat, lung inflammation 
[11], eicosanoid generation in leukocytes [12] and carrageenan-
induced paw edema [13]. Although Tq possesses excellent therapeutic 
potential but has failed to meet the clinical demand because of poor 
solubility and dissolution [14]. Hydrophobic drugs when delivered 
orally encounter permeability problems first followed by poor 
bioavailability and extensive hepatic metabolism. Because of these, the 
clinical applicability of Tq has been significantly hampered.  
The development of transdermal drug delivery systems (TDDS) 
designed to have local as well as systemic effects is advisable and 
beneficial especially when we talk about anti-inflammatory activity. 
Several studies showed tremendous advancement in terms of 
bioavailability and acceptance that TDDS offered over conventional 
routes of drug administration [15-17]. But, TDDS is also restricted 
by the skin, a natural barrier. With the combined effort of biomedical 
science and engineering, chemical enhancers (synthetic and natural) 
and techniques such as ultrasound and iontophoresis have been 
designed to minimize the skin impermeability. 
The use of synthetic penetration enhancers sometimes irreversibly alter 
the natural defence of skin and toxicity at application site [18]. 
Therefore, it has been advised to use novel formulation approaches to 
overcome permeation problem associated with penetration enhancers. 
A wide variety of drug carriers including nanoemulsions, micro-
emulsions, liposomes, solid lipid nanoparticles, microspheres, and self-
micro emulsifying drug-delivery systems have been studied to improve 
the therapeutic efficacy of hydrophobic drugs or nutraceuticals by 
enhancing the bioavailability and tissue-targeting ability [17]. Among the 
various novel drug delivery systems, nanocarrier system has emerged as 
a best alternative and timely for TDDS. Nanoemulsion, a most stable 
nano-carrier system has combined the advantages of other innovative 
carrier systems with highest kinetic and thermodynamic stability, 
excellent acceptance and minimal inter-subject variability [19]. 
Nanoemulsions have been widely studied to increase the bioavailability 
of hydrophobic drugs [20-23].  
Nanoemulsion droplet, because of its excellent flexibility can 
penetrate the intact stratum corneum spontaneously either through 
intracellular route or Trans-cellular route without much affecting 
the integrity of the skin [24].  
Viewing the safety issue and patient acceptance, especially for local 
anti-inflammatory activity, the present investigation was aimed to 
formulate an emulsion of the nanometric size range for Tq to obtain 
local as well as systemic effects and hence avoid pre-systemic 
clearance. This may lead to a decrease in systemic side effects. 
Despite the little limiting factor, numerous advantages are 
associated with TDDS. It is a best alternative route for drugs with a 
low oral bioavailability and extensive hepatic metabolism hence 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491               Vol 10, Issue 7, 2018 
Ahuja et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 7, 41-51 
42 
providing controlled drug input and high patient acceptance and 
compliance. 
MATERIALS AND METHODS  
Materials 
Propylene glycol monocaprylate (Capryol 90), caprylo caproyl 
macrogol-8-glyceride (Labrasol) and diethylene glycol monoethyl 
ether (Transcutol® P) were obtained from Gattefosse (Saint-Priest, 
Cedex, France). Propylene glycol mono caprylic ester (Safsol 218) 
was obtained from Nikko Chemicals (Tokyo, Japan). 2-propanol 
high-pressure liquid chromatography (HPLC) grade, methanol HPLC 
grade, and water-HPLC grade were procured from SD Fine 
Chemicals, Ltd. Nigella sativa EO, polyoxyethylene (20) sorbitan 
mono oleic acid (Polysorbate 80®), polyoxyethylene (20) sorbitan 
monolaurate (Polysorbate 20®
Analytical methodology 
), polyethylene glycol (PEG 200) and 
ethanol were purchased from GuideChem (Riyadh, KSA). Dialysis 
tubing (mol wt cut-off: 12,000 Da, flat with 25 mm, diameter of 16 
mm, capacity 60 ml/ft) was obtained from Sigma-Aldrich (St. Louis, 
MO, USA). All other reagents used were of analytical grade. 
The content of Tq in Nigella sativa EO was estimated by reported HPLC 
analysis using Shimadzu LC 2010 system (Kyoto, Japan) which 
consisted of quaternary LC-10A VP pump, SPD-10AVP column oven 
and variable wavelength programmable UV/VIS detector. The analysis 
was carried out on a LiChrospher®C18
Solubility study in the oil phase and surfactant 
 (150 mm×4.6 mm i.d., 5 µm 
particle size) column (Agilent Technology, California, USA). The mobile 
phase consisted of 2-propanol (5%v/v), methanol (5% v/v) and water 
(50% v/v) having with pH 6.8. The flow rate was maintained at 2.0 
ml/min and the retention time was 3.2 min. Ultraviolet detection 
was optimum at 294 nm for Tq [25]. The assays were performed at 
ambient temperature (25±0.5 °C) and Class VP 5.03 version 
software was used to process the chromatograms. The same method 
was used for all the analytical activities. 
The solubility of Nigella sativa EO in different oil phases and 
surfactants was determined using isothermal water shaker 
maintained at 37±0.5 °C. For determining the solubility in an oil 
phase, different ratios (0.01 to 0.5% v/v) of oil and Nigella sativa EO 
were added to the stoppered vial (5 ml capacity) containing 2 ml of 
an oil phase. The vials were kept in the isothermal shaker for 72 h 
for equilibration. Solubility study of Nigella sativa EO was also 
conducted in different co-surfactants and surfactants. The vials were 
visualized against the bright light to observe any phase separation 
or boundary layers and precipitation [26]. After 72 h, the samples 
were taken out and passed through the membrane filter and the oil 
sample was assayed using visual clarity. 
Construction of pseudo-ternary phase diagram  
Pseudo-ternary phase diagrams were constructed to find out the 
concentration range of various components to understand the 
existence range in the nanophasic zone [26, 27]. Pseudo-ternary 
phase diagrams of the oil phase, aqueous phase, and co-surfactant 
(CoS)/surfactants (S) mixtures (Smix) were constructed at fixed 
CoS/S weight ratios. Here, Nigella sativa EO: capryol 90 mixture was 
used as an internal phase (oil) whereas a mixture of tween 80 and 
PEG 200 was used as Smix. Distilled water was used as an external 
aqueous media for nanoemulsion titration. Surfactant and co-
surfactant (Smix) were pre-mixed in different volume ratios (1:0, 1:1, 
1:2, 1:3, 2:1, 3:1, and 4:1). For each phase diagram, sixteen different 
combinations of oil and Smix (1:9, 1:8, 1:7, 1:6, 1:5 1:4, 1:3.5, 1:3, 3:7, 
1:2, 4:6, 5:5, 6:4, 7:3, 8:2 and 9:1) were made. Pseudo-ternary phase 
diagrams were established by aqueous titration method. Slow 
titration with aqueous phase was done for each combination of oil 
and Smix
Physical stress tests  
 separately [19]. The existence of nanoemulsions regions 
was marked on a pseudo-ternary phase diagram with axes 
representing the aqueous phase, oil phase and the mixture of 
surfactant and co-surfactant at fixed volume ratios. After 
constructing the pseudo-ternary phase diagrams, optimal surfactant, 
co-surfactant and oil combinations were selected for formulation 
development. 
Different formulations were selected from the phase diagram showing 
nanoemulsion region on the basis of Nigella sativa EO miscibility with 
the oil phase. The minimum concentration of Smix with external phase 
concentration (water) must be greater than the internal phase (oil 
phase). To overcome the problem of metastable formulation, physical 
stress tests were performed [24, 26]. To get robust formulation and to 
overcome the problem of metastability, physical stress tests were 
performed as already discussed in various studies [28].  
Centrifugation tests 
Selected formulations (NanoTq) were centrifuged (K241R 
Refrigerated Model) at 5000 rpm for 30 min and observed for phase 
separation, creaming or cracking, turbidity and drug precipitation. 
The formulations that showed any of the mentioned thermodynamic 
stability problems were excluded from remaining stress tests.  
Heating cooling cycle  
Six heating-cooling cycles between heating temperature (45±0.5 °C) 
and refrigerator temperature (0±0.5 °C) were performed with 
storage at each temperature for not less than 48 h. Those 
formulations, which were stable at this temperature cycle with no 
phase separation, creaming or cracking, turbidity and drug 
precipitation, were subjected to freeze and thaw cycle.  
Freeze-thaw cycle (Accelerated ageing) 
In freeze and thaw cycle, selected formulations were exposed to 
three freeze-thaw cycles between-21±0.5 °C and+25±0.5 °C with 
storage at each temperature for not less than 48 h. 
In vitro permeation study 
In vitro permeation study was performed using dialysis bag 
supported Franz diffusion permeation cell and the mixture of 
acetate buffer (pH 5.4) and Tween 20 (1.0 % w/v) as a dissolution 
medium [29]. Only those formulations were included in permeation 
which survived physical and thermodynamic stress tests (table 1). In 
permeation study, one ml of optimized formulation (table 1) was 
placed in a treated dialysis bag (MWCO 12,000 g mole-1
Refractive index 
; Sigma, St. 
Louis, MO, USA) and at predetermined time intervals (0, 0.25, 0.5, 
0.75, 1, 2, 5, 6, 10 and 12 h) 0.5 ml sample was withdrawn. To 
maintain the sink condition of dissolution medium, withdrawn 
volume was replenished with the same amount of fresh acetate 
buffer. The samples were diluted with methanol and analyzed for 
the drug content by reported RP-HPLC at 294 nm [25].  
Refractive index (Rf) of the optimized formulations NanoTq was 
determined by ABBE type refractometer. In Rf  study, cedarwood oil 
was used as a reference. Rf
Transmittance 
 was measured by placing drops of 
formulation solution on the slide. 
Transmittance is the fraction of incident light at a specified wavelength 
that passes through a sample. It was assumed that, if the diameter of 
the dispersed phase is below the wavelength of transmitted light, it 
will easily pass through the sample without any absorbance. 
Percentage transmittance of NanoTq was measured at 630 nm (visible 
range) using UV spectrophotometer (UV 1601, Shimadzu, Japan) 
keeping the distilled water as a reference solution [30]. 
Viscosity measurement 
The viscosity of the optimized formulation was estimated by 
Brookfield DV III ultra V6.0 RV cone and plate rheometer (Brook-
field Engineering Laboratories, Inc, Middleboro, MA) with spindle # 
CPE40. All measurements were carried out at a constant 
temperature of 25±0.5 °C. The software used for the calculations 
was Rheocalc V2.6. 
Droplet size and zeta potential  
Droplet size was estimated by photon correlation spectrometer 
(PCS; Zetasizer-1000 HAS, Malvern Instruments, UK) which converts 
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fluctuations in light scattering (25°C; angle: 90°) into the diameter. 
Test samples were dispersed in 50 ml (100 to 1000 x dilutions) of 
distilled water and were used for droplet size analysis. Mean droplet 
size (Δdm) and polydispersity index (pi) were recorded. 
Surface charge or zeta potential (ζ) measurements were carried out 
after dispersing the test samples in 50 ml of distilled water. A 
potential difference across the dispersion medium was established 
to determine the zeta potential. The charged droplets within the 
dispersion medium migrated towards the electrode of opposite 
charge. The migration velocity is proportional to the magnitude of 
the zeta potential.  
Surface morphology (TEM) 
Surface morphology and shape of the optimized formulation were 
studied by transmission electron microscope (TEM) (TOPCON 002B) 
operating at 200 KV, capable of a point to point resolution. Diluted 
samples (dilution factor, 1:1000) of nanoemulsion system were used 
for TEM observations. The sample was negatively stained with 
phosphotungstic acid. A drop of diluted NanoTq was allowed to 
deposit directly on the circular copper film grid of 400 mesh and 
stained with 2% (w/v) phosphotungstic acid for 30 s and placed for 
observation after air drying. Combination of bright field imaging at 
increasing magnification and diffraction modes were used to 
determine the form and size of the nanoemulsion. 
Formulation development 
The optimized nanoemulsions after in vitro characterization and 
optical study were converted into a gel. NanoTq Gel, apiTqGel and 
DicloGel was prepared after homogenous dispersion in Carbopol-
934 gel. Carbopol gels (0.5% w/v) was prepared after dispersing in 
distilled water and kept in dark for 24 h for complete swelling. The 
carbopol gel was stabilized by drop-wise addition of triethylamine. 
The optimized NanoTq, apiTq and diclofenac was added slowly into 
the gel with continuous stirring. The obtained gel was left for 24 h to 
get homogeneous dispersion. 
Ex vivo permeation study 
The rat abdominal surface hair was removed by a clipper and skin 
(full thickness) was surgically removed. The subcutaneous layer was 
removed manually and dermis side was wiped with isopropyl 
alcohol. The full thickness of skin was soaked in buffer solution 
(phosphate saline) and stored at −20±0.5 °C till further use. Ex vivo 
skin permeation was performed by the Franz diffusion permeation 
cell with an effective diffusion surface area of 0.636 cm2
Cumulative % drug permeated through the skin was plotted as a 
function of time (t). Permeation rate at steady state (Jss) was 
calculated by dividing the slope of the linear portion of graph with 
diffusion area. Similarly, permeability coefficient (Kp) was estimated 






excised rat abdominal skin. The skin was mounted between donor 
and receiver compartments of the Franz diffusion cell facing stratum 
corneum toward the donor compartment and dermal side facing the 
receiver compartment. Multiple cycles, skin stabilization was done 
with dissolution medium. For this, the receiver chamber was filled 
with acetate buffer pH 5.4 with 1% (w/v) sodium lauryl sulfate (SLS) 
and stirred with magnetic beads (100 rpm) maintained at 37±0.5 °C. 
The whole dissolution medium was replaced with a fresh one after 
every 30 min for complete stabilization of the skin. After running 12 
cycles of stabilization, 2.0 g of NanoTq was placed into the donor 
compartment. The samples were withdrawn at regular time 
intervals (0.25, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16 and 24 h). The 
withdrawn samples were passed through a 0.45 μm membrane filter 
and analyzed for drug content by an RP-HPLC method.  
The permeation enhancement ratio (Er) was also calculated using 
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Short term storage stability study 
The effect of short-term storage stability on droplet growth, surface 
charge, and drug content was estimated after storing formulations at 
regulated temperature and humidity for a period of 90 d. Initially, 
droplet size and zeta potential measurements were carried out for 
NanoTq formulation. Properly sealed samples were stored at 
regulated temperature and humidity (40±2°C, 65±5% RH) 
conditions. Samples were withdrawn after 90 d for particle size, zeta 
potential and drug content measurements [24]. 
Anti-inflammatory study 
NanoTq formulations showing excellent ex vivo permeation and 
short-term storage stability profile were selected for the anti-
inflammatory study. The anti-inflammatory studies on the optimized 
NanoTq formulation were performed on carrageenan-induced hind 
paw edema method using Wistar rats [31]. Wistar rats weighing 
150–200 g, were randomized into four groups having six rats in each 
group. The groups were classified on the basis of formulations given 
like NanoTq, ApiTq, standard diclofenac and a saline control. The 
animals were housed in polypropylene cages (6 per cage), with free 
access to standard laboratory diet and water ad-libitum. Rat dose 
was calculated based on the weight of the rats according to the 
surface area ratio method [32]. Formulation NanoTq Gel and apiTqGel 
were applied on the shaved abdominal region of all animals, half an 
hour before sub plantar injection of salinated carrageenan suspension 
(1% w/v) in right paw. The volume of paw was measured using digital 
plethysmometer (LE 7500, Panlab Harvard Apparatus) at specific time 
intervals (0.5, 1, 2, 3, 6 and 12 h). Basically, the volume transducer was 
formed by two Perspex tubes interconnected and filled with a 
conductive solution and a platinum electrode for each chamber. The 
water displaced after immersion of inflamed rat paw in the measuring 
tube was deflected into the second tube, inducing a change in the 
conductance between the two platinum electrodes. Per cent inhibition 
of edema produced by gels treated group was calculated against the 
respective control group and marketed DicloGel (RUMAFEN®
RESULTS AND DISCUSSION 
, Riyadh 
Pharma, Riyadh, KSA). The results of anti-inflammatory effects were 
compared using Dunnett test of one-way analysis of variance. The 
study was approved from Animal Ethical Committee, College of 
Pharmacy, Dawadmi Campus, Shaqra University, and Kingdom of 
Saudia Arabia and confirms to National guidelines on the care and use 
of laboratory animals. 
Solubility study in oil phase and surfactant 
A preliminary study showed very limited nanoemulsion region when 
Nigella sativa EO was used as an oil phase. Therefore to get 
nanophasic region, dilution of Nigella sativa EO with some suitable 
oils was a pre-requisite. Solubility or miscibility study showed 
Nigella sativa EO had limited solubility in selected oil phases (fig. 
1a). However, Nigella sativa EO showed good solubility in safsol 228 
(26.41±2.84 % v/v) and capryol 90 (33.34±1.61 % v/v). Therefore 
capryol 90 was used as co-solvent to make the oil as an internal 
phase. The co-solvency study showed good miscibility of capryol 90 
with Nigella sativa EO (30% v/v) with no phase separation even 
after centrifugation (5000 rpm for 5 min). For the present study, a 
combination of Nigella sativa EO (30% v/v) and capryol 90 (70% 
v/v) was selected to make the internal phase (fig. 1a).  
Similarly, based on solubility data, surfactants tween 80 and PEG 
200 showed significantly high (p<0.01) solubility compared to 
cremophor EL, transcutol-P and tween 20 (fig. 1b). Therefore, tween 
80 and PEG 200 were selected as a Smix for developing NanoTq 
formulations. 
Construction of pseudo-ternary phase diagram 
Pseudo-ternary phase diagrams were constructed to find out 
concentration range of various components for the existence range 
of nanophasic zone by aqueous phase titration technique at room 
temperature (25±0.5 °C). During aqueous phase titration, the 
metastable formulation was excluded [23]. Here polysorbate 80 and 
Polyethylene glycol 200 were used as a surfactant and co-surfactant 
respectively. Both were pre-mixed in different volume ratios to get 
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maximum possible combinations. These Smix ratios were chosen in 
increasing concentration of co-surfactant with respect to surfactant 
(Surfactant: Co-surfactant: : 1:0, 1:1, 1:2, 1:3 v/v) and vice versa 
(Surfactant: Co-surfactant: : 2:1, 3:1, 4:1). The nanophasic area 
observed during phase titration was drawn the different phase 
diagram (fig. 2). During aqueous titration, the metastable nanogel 
region spontaneously converted into nanoemulsion region. Because 
of instability, it leads to failure of the system. Therefore, care was 
taken to discard formulation points coming in this region (fig. 2). In 
the phase diagram of Smix with high contribution of co-surfactant, a 
decreasing trend of the nanophasic region was observed. On the 
other hand, in the phase diagram of Smix with high contribution of 
surfactant, an increasing trend of the nanophasic area was obtained. 
The nanophasic area observed in Smix 1:1 to 1:3 was very 
insignificant. Similarly, the phase diagram without co-surfactant 
gave large liquid crystalline (LC) region or metastable region that 
was unable in breaking the oil-water interfacial tension. But after 
adding co-surfactant (Smix 4:1, 3:1 and 2:1), an increased 
nanophasic area was obtained. The co-surfactant made interfacial 
film more flexible leading to decrease in LC area. After observing 
nanoemulsion, it may be concluded that free energy of 
nanoemulsion formation is somehow dependent on the extent that 
how efficiently a partcular Smix lowers the interfacial tension 
between oil-water interface [23, 33]. The free energy and dispersion 
entropy lead to the spontaneous formation of thermodynamically 
stable nanoemulsion [34, 35]. Therefore, while selecting the 
formulations composition from each phase diagrams, the care was 
taken to select those which could accommodate an optimum 
quantity of oil phase by using lowest possible Smix to further avoid 
the possibility of liquid crystallinity or metastability gel region. 
 
 
Fig. 1a: Percentage solubility study of Nigella sativa EO in different synthetic oils. The data represented as mean±sd (n=3) 
 
 
Fig. 1b: Percentage solubility study of Nigella sativa EO in different surfactants. The data represented as mean±sd (n=3) 
 
Formulation development  
The phase diagrams of Smix 1:0 and 1:1, had maximum 
nanophasic regions with the liquid crystalline region. The LC 
region, although converted spontaneously into the nanoemulsion 
but was unable to pass the thermodynamic stress tests. These 
regions comprised of the large extent of LC region whereas Smix 
1:2, 1:3 and 1:4 gave very limited nanoemulsion region which was 
also associated with the LC phase in apex region. The phase 
diagram consisted of Smix 1:1, 2:1, 3:1 and 4:1 and showed 
progressive and thermodynamically stable nanoemulsion with 
insignificant LC and metastable regions. Different formulations 
were selected from different pseudo-ternary phase diagrams with 
justified Tq dose considering the drug solubility in the oils phase 
(table 1). Therefore, from each phase diagram different 
concentrations of oil, at which nanoemulsions formed, were 
selected at a difference of 2% (10, 12, 14, 16 and 20%) so that 
maximum formulations could be selected covering the 
nanoemulsion area of the phase diagram. Almost in all cases, Smix 
concentration up to 40% of the total formulation was selected. 
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Fig. 2: Pseudo-ternary phase diagrams of nanoemulsion regions obtained using different surfactant: co-surfactant combinations (Smix) 
 
Physical stress tests  
To obtain robust formulation and to over-counter metastable, 
thermodynamic stability/physical stress tests (centrifugation, heating–
cooling cycle and freeze-thaw cycle) are recommended [19, 27]. During 
stability stress testing, it was observed that some formulations became 
turbid and the phase separated. One reason of this instability may be due 
to Ostwald ripening in which stabilizing molecules move as a monomer 
which leads to coalescence of the smaller droplet into large droplets. The 
larger droplets lead to phase separation during centrifugation stress 
tests. Similarly, during the heating-cooling cycle, there is temperature 
quench leading to instability of nanoemulsion. 
 
Table 1: Different thermodynamic stress tests of selected nano-formulations from pseudo-ternary phase diagrams 
Smix ratio  
(S: CoS) 
Formulation code Compositions (v/v) Stress stability tests 
Omix Smix Water H/C Cent Freez/Thaw 
1:0 
(Code G) 
10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ x - 
16% 16 - - - - - 




10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ √ √ 
16% 16 - - - - - 




10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ √ √ 
16% 16 - - - - - 




10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ x - 
16% 16 - - - - - 




10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ √ √ 
16% 16 35 49 √ √ X 




10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ √ √ 
16% 16 35 49 x - - 





10% 10 29 61 √ √ √ 
12% 12 31 57 √ √ √ 
14% 14 33 53 √ √ √ 
16% 16 35 49 √ x - 
20% 20 37 43 √ x - 
Note: Tq-PEG (1:1) mixture (Omix), Surfactant-Co-surfactant ration (Smix), Heating-cooling cycle (H/C), Centrifugation study (Cent), Freeze-thaw 
cycle (Freez-Thaw). 
 
The temperature quenching lead to small droplet size which favours 
Brownian movement which helps in efficiently re-distributing the 
particles to an equilibrium configuration with the lowest total free 
energy [35].  
Sometimes, over dilution leads to leaching the stabilizers from 
interface to the bulk medium. This process also hastens during 
centrifugation stress and hence phases separation. Formulations 
that showed no phase separation, creaming, cracking, coalescence 
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and phase inversion during stress stability tests were selected 
(table 1).  
In vitro permeation study  
The release of Tq from optimized formulations consisting of 10% oil 
phase was significantly high (p<0.01) compared to formulations 
consisting of 12% oil phase. Drug release from NanoTq B was very 
rapid initially, as 91% of the drug was released in 12 h. When we 
compared ≥80% drug release graph ( fig. 3), it was very clear that 
most of the formulations with 10% oil composition released approx 
80% drug content in less than 8 h. Compared to 10% composition, 
only two formulations i.e. NanoTq B and NanoTq C consisting of 
12% oil phase were able to release 80% drug in quick fashion. This 
could be the consequences of efficient droplet nanosizing and least 
polydispersity index. The order of drug release pattern from 
optimized formulations with 12% oil phase were NanoTq B (Smix 
3:1)>NanoTq C (Smix 2:1)>NanoTq F (Smix 1:1)>NanoTq A (Smix 
4:1)>NanoTq E (Smix 1:2)>NanoTq D (Smix 1:3) in 12 h. While, drug 
release order from formulations with 10% oil phase were NanoTq B 
(Smix 3:1)>NanoTq C (Smix 2:1)>NanoTq A (Smix 4:1)>NanoTq F (Smix 
1:1)>NanoTq E (Smix 1:2)>NanoTq D (Smix
Transmittance and refractive index 
 1:3). Although 
formulations consisting of 10 % oil phase were rapid in drug release 
but they were found to be metastable nanogels. It was found that 
metastability interfered with emulsification leading to varied drug 
release pattern (fig. 3).  
The droplet size of formulations is inversely proportional to 
percentage transmittance; therefore higher the value of %T, lower the 
droplet size of the formulation [28].  
The percentage transmittance is based on UV-spectrophotometer 
which uses visible light wavelength. The %T approaching 100% 
indicates that the dispersed phase and dispersion medium are alike 
which means isotropy with aqueous phase. The results showed that % 
T of all selected NanoTq formulation ranged between 91.34±21.35 to 






Fig. 3: Permeation study of optimized formulation. The data presented as the mean±sd (n=3) 
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Table 2: Comparative characterization of the optimized formulations 








Zita potential (mV) 
(mean±sd) 
NanoTq A10% 96.12±15.56 1.369±0.0239 107.28±19.43 142.09±23.04 32.43±4.19 
NanoTq B10% 98.67±7.13 1.359±0.0205 87.13±11.33 134.74±26.17 31.53±5.38 
NanoTq C10% 101.71±11.92 1.362±0.0273 96.44±13.64 128.49±15.82 27.03±2.53 
NanoTq D10% 94.34±21.35 1.364±0.0264 122.93±15.16 103.91±11.52 20.47±7.39 
NanoTq E10% 95.55±18.42 1.365±0.0216 112.17±17.35 109.12±15.26 22.01±5.34 
NanoTq F10% 96.43±10.26 1.366±0.0259 102.95±21.42 118.15±13.88 26.21±6.63 
Note: All data is the average finding of three experimental outcome and expressed as the mean±standard deviation. The notation used are; 
transmittance (%T), refractive index (Rf), particle size distribution (Σd), viscosity (ηm
 
The decreasing order of percentage transmittances were as NanoTq 
C10%>NanoTq B10%>NanoTq F10%>NanoTq A10%>NanoTq 
E10%>NanoTq D10%. The optimized formulation NanoTq C10% 
obtained from Smix 2:1 phase diagram showed maximum 
transmittance. Formulations consisting of high Smix 4:1 to 2:1 ratio 
showed the increasing order of %T. On the other hand, formulations 
consisting of Smix 1:3 to 1:1 ratio showed the increasing order of 
%T. The results conclude that nanosizing and transmittance are the 
combined effects of Smix on interfacial film flexibility.  
Refractive index (R
), zeta potential (ζ), polydispersity index (pi), standard 
deviation (sd), milli volt (mV). 
f) is used to characterize the isotropic nature of 
the nanoformulations and also suggests the colour chemical 
interaction, turbidity and precipitation among drug and excipients. 
The Rf value of all the optimized formulations are mentioned in the 
table (table 2). The least value of Rf
The droplet size distribution and surface charge analysis were 
performed by Malvern zetasizer (Nano ZS-90 UK). The mean droplet 
sizes of the differently optimized nanoemulsions are shown in table 
2. It was observed that in all cases diameters of the optimized 
formulations were below 125 nm, proving the existence of 
nanoemulsion region (fig. 4A). The order of average droplet sizes 
were NanoTq D10% (122.93±15.16 nm)>NanoTq E10% 
(112.17±17.35 nm)>NanoTq A10% (107.28±19.43 nm)>NanoTq 
F10% (102.95±21.42 nm)>NanoTq C10% (96.44±13.64 
nm)>NanoTq B10% (87.13±11.33 nm). The droplet size results 
showed that compositional variability is the major deciding factor 
for interfacial film flexibility and hence droplet size. The flexibility of 
interfacial films is a pre-requisite for effective nanosizing [36]. 
Results showed that co-surfactant aided in creating sufficient 
flexibility to the interfacial films that is required for secondary 
nanosizing, but it will not be effective for nanosizing if Smix is below 
the required HLB. Similarly, high surfactant concentration although 
increases the HLB value but the droplet size was more, which may 
be the consequence of rigid interfacial film leading to improper 
emulsification and hence nanosizing. Therefore, proper composition 
selection and functional role of different components is important 
for nanosizing and hence optimum bioavailability. Similar to flexible 
interfacial films, zeta potential or surface charge is equally 
important in deciding the fate of formulation stability. The zeta 
potential close to±25 mV minimizes the contact angle and hence 
provides maximum stability [24]. The zeta potential results of all the 
optimized formulations varied between 20.47±7.39 to 31.53±5.38 
mV (table 2) which comes under safe stability range (fig. 4B). The 
order of zeta potential were found to be NanoTq D10% (20.47±7.39 
mV)>NanoTq E10% (22.01±5.34 mV)>NanoTq A10% (32.43±4.19 
mV)>NanoTq F10% (26.21±6.63 mV)>NanoTq C10% (27.03±2.53 
mV)>NanoTq B10% (31.53±5.38 mV). 
Surface morphology (TEM)  
 was 1.359±0.0205 for NanoTq 
B10% whereas it was maximum for NanoTq A10% respectively. 
Viscosity measurement 
The viscosity of the optimized formulations was determined as 
shown in table 2. The viscosity results can be correlated with the 
different ratios of the surfactants as well as co-surfactants used in 
the stabilization of selected formulation composition. It was 
observed that the viscosity of all the formulations was less than 145 
mPas. Formulation viscosity of NanoTq D and NanoTq E was shown 
as 103.91±11.52 and 109.12±15.26 mPas respectively which was 
significantly (p<0.01) low as compared to the other formulations 
(table 2). The low viscosities of all formulations met the expected 
criteria as required for better emulsification and spreadability. 
Droplet size and zeta potential  
Transmission electron microscopy is the most important technique 
to study the shape of nanometric structures because it directly 
produces the point to point images at high resolution. The 
morphology of droplet determined by TEM is shown in fig. 4. The 
morphology of Tq loaded nanodroplet (nearly spherical), could be 
observed in the fig. TEM imaging of the optimized NanoTq has 
shown a good agreement with the droplet size distribution data (fig. 
5, table 2). The droplet had smooth edges and was uniformly 
distributed. Overall, the results justifying the narrow polydispersity 
index was as obtained in the particle size distribution study. 
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Fig. 4: Dynamic light scattering technique for determining the particle size distribution (A) and zeta potential (B) of the optimized 
formulation (NanoTq B 10%) 
 
Ex vivo permeation study 
Ex vivo skin permeation studies were done to compare permeation 
profile of Tq from different NanoTq formulations and suspension of 
apiTq (ApiTqGel) using a small fragment of abdominal rat skin as a 
permeation barrier (fig. 6). Acetate buffer (pH 5.4) with 1% (w/v) 
sodium lauryl sulfate (SLS) was added in receiver compartment of 
Franz diffusion cell in order to maintain the sink condition. 
Maximum ex vivo skin permeation was exhibited for NanoTq 10% 
and lowest in case of ApiTqGel (fig. 5). Ex vivo permeation showed 
good correlation with dialysis bag supported in in vitro permeation 
study. The small droplet size with the larger surface area, least 
polydispersity index, and favorable zeta potential is the favorable 
condition for enhancing the flux of NanoTq 10% [37]. The lipidic 
bilayer nature of stratum corneum favours easy dissolution of the 
drug encapsulating in lipid domain [18, 26]. Similarly, water is a 
natural penetration enhancer for both hydrophilic and hydrophobic 
molecules. Hydrated skin, causing reversible separation of lipid 
bilayers of SC intercellular space to form cisternae, and networks of 
spherical particulates are observed in porcine skin tissue after 4–10 
h treatment with water [18, 38]. Furthermore, PEG 200 which is 
present in the optimized formulation causes an alteration in the 
stratum corneum and thereby aids in partitioning for better 
absorption. 
Permeability flux (Jss), permeability coefficient (Kp) and permeation 
enhancement ratio (Er) were significantly increased by NanoTq 10% 
compared to ApiTqGel (p<0.001). The particle size difference of 
NanoTq A10% and NanoTq F10% formulations was insignificant but 
the flux difference was quite significant. The result showed the 
significance of compositional variable which not only decides the 
droplet size but also the flexibility of interface required for re-
nanosizing and permeation. The order of steady-state flux calculated 
for the selected formulations was NanoTq A10%>NanoTq 
B10%>NanoTq C10%>NanoTq D10%>NanoTq E10%>NanoTq 
F10%, as reported in table 3. Surprisingly, the flux of NanoTq B and 
NanoTq C were found almost similar, although there were different 
particle size distribution and Smix ratio. This proved the significance 
of interfacial film in permeation. The comparative permeation 
enhancement ratio was highest for NanoTq A10% and least for 
NanoTq F10%. Other permeability parameters of different 
formulations are shown in table 3. 
 
Table 3: Comparative Ex vivo permeability parameter of different NanoTq formulation and NeatTq formulation 
Formulation Flux (Jss±sd; µg/cm2 Permeability constant (Kp±sd; cm/h) /h) Enhancement ratio (Er) 
NanoTq A10% 6.354±0.635** 0.116±0.075 4.37** 
NanoTq B10% 5.701±0.865** 0.104±0.06 3.92** 
NanoTq C10% 5.691±0.792** 0.103±0.012 3.91** 
NanoTq D10% 5.424±0.537* 0.099±0.056 3.73* 
NanoTq E10% 5.415±0.362* 0.096±0.017 3.72* 
NanoTq F10% 5.158±0.819** 0.106±0.014 3.55** 
NeatTq 1.452±0.635 0.026±0.019 - 
Note: Data presented here is the average of three experiments trial and expressed as the mean±standard deviation. Here p*<0.05, p*<0.01 and 
p*<0.001  
 
Short term storage stability studies  
Short term storage stability of the optimized formulations was evaluated 
by size distribution and zeta potential measurements using dynamic 
light scattering; visual observation of macroscopic changes including 
phase separation or creaming and drug precipitation. After storing for 
180 d (45±0.5°C/75%±0.5 RH), the formulations were critically 
evaluated. Visual observation showed no phase separation and drug 
precipitation. Similarly droplet size study and zeta potential showed 
very insignificantly (p*<0.001) changes as shown in table 4. 
Anti-inflammatory study  
Comparative anti-inflammatory effects of the optimized 
nanoformulation (NanoTq) and apiTq were evaluated using 
Plethysmometer. The water displaced after immersion of rat paw in 
measuring tube changed the conductance between platinum 
electrodes. The percentage anti-inflammatory effects post 12 h 
carrageenan application followed by NanoTq application was 
insignificant for NanoTq B 10% (72.54%) as compared to standard 
DicloGel (79.26%) were as highly significant (p*<0.001) as compared 
to apiTqGel (26.86%) as shown in fig. 7. 
The effectiveness of apiTqGel was very poor even after 12 h. This 
may be because of poor solubility and dissolution problem leading 
to poor permeation (fig. 6 and 7). 
Earlier report favours significant suppression of monocyte chemo 
attractant protein-1 promoter, inhibition of TNF-α, IL-1β, NO, PGE2, 
production of NF-kappa B, and reduced transport of NF-kappa B 
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from the cytosol to the nucleus by Tq [39, 40]. The enhanced anti-
inflammatory effects of NanoTq were due to efficient penetration 
and attainment of high therapeutic concentration at the localized 
area as well as into the systemic circulation. The macromolecular 
size of aqueous Tq solution compared to a nanometric range of 
NanoTq caused inefficient penetration. 
  
Table 4: Storage stability study performance at a regulated temperature (45±0.5 °C) and humidity (75%±0.5 RH) 
Formulation Day one sampling Day 90th sampling (45±0.5 °C/75%±0.5 RH) 
Σd±sd (nm) ζ±sd (mV) Σd±sd (nm) ∆d (%) ζ±sd (mV) ∆ ζ (%) 
NanoTq A10% 107.28±19.43 36.43±4.19 113.26±9.35 5.57 31.92±3.68 12.38 
NanoTq B10% 87.13±11.33 31.53±5.38 89.62±8.47 2.86** 30.23±1.18 4.12** 
NanoTq C10% 96.44±13.64 28.03±2.53 101.33±7.91 5.07 26.63±4.03 4.99** 
NanoTq D10% 122.93±15.16 24.47±7.39 128.85±10.45 4.82 19.19±3.47 21.58 
NanoTq E10% 112.17±17.35 25.01±5.34 119.40±9.93 6.45 22.41±4.12 10.40 
NanoTq F10% 102.95±21.42 26.21±6.63 111.38±8.12 8.19 22.89±4.97 12.67 
Note: Particle size distribution (Σd), Zeta potential (ζ), Standard deviation (sd), milli volt (mV), Experimental data were triplicate and expressed as 
the mean±standard deviation (n=3)  
 
 
Fig. 5: Transmission electron microscopic (TEM) imaging of NanoTq showing the shape of oil-droplet 
 
 
Fig. 6: Comparative ex vivo permeation study of optimized Tq formulations (NanoTq A-F) and apiTq using Franz diffusion cell. Acetate 
buffer (pH 5.4) with PEG 200 (1% w/v) was used as dissolution medium 
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Fig. 7: Comparative anti-inflammatory response of (a) standard diclofenac suspension (b) NanoTq and (c) apiTq on the carragenan-
induced paw edema in rats. Each point represents mean±sd (n=6). Here p*<0.005, p**<0.001 and p***<0.0001 
 
CONCLUSION 
The composition of nanoparticulate formulations is playing an important 
role in the effective transdermal delivery system. On the basis of 
polydispersity index, zeta potential, droplet size, drug permeation study 
and optimum Smix concentration, NanoTq B 10% was selected as an 
optimized formulation. Anti-inflammatory activity of the optimized 
NanoTq was increased with the shortened lag times in comparison to 
apiTq. Short term storage stability at regulated temperatures and 
humidity showed insignificant changes in mean diameters, zeta potential 
with no any observable physical changes. This proved good shelf-life of 
the optimized formulation. The carrageenan-induced rat paw edema 
results further potentiate NanoTq B 10% as a promising vehicle for 
improved transdermal delivery. Anti-inflammatory potential of NanoTq 
B was found equally effective as standard DicloGel whereas significantly 
high compared to apiTq. Thus, the optimized formulation NanoTq B 
could be used as an effective potential anti-inflammatory agent. These 
studies no doubt need further optimization to make the optimized 
formulation more effective. 
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